Dual Antiplatelet Therapy after Coronary Drug-eluting Stent Implantation in China: A Large Single Center Data

@inproceedings{Xu2017DualAT,
  title={Dual Antiplatelet Therapy after Coronary Drug-eluting Stent Implantation in China: A Large Single Center Data},
  author={Jingjing Xu and Zhan Gao and Ying Song and Xiao‐Fang Tang and Lin Jiang and Xiang Zhao and Yin Zhang and Lijian Gao and Jue Chen and Shubin Qiao and Run-lin Gao and Ye Yang and Bo Xu and Jinqing Yuan},
  year={2017}
}
We investigated the real dual antiplatelet therapy (DAPT) duration after the drug-eluting stent (DES) treatment in China. 9,919 consecutive patients with DES implantation were enrolled. The follow-up DAPT cessation and associated factors with different DAPT durations were analyzed. The proportion of patients with DAPT coverage at 1-year follow-up was 97.3%, and decreased to 30.1% for 2-years. The distribution of DAPT duration ( 1 year) was not significantly different among patients presented… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

2155-166

L Mauri, DJ Kereiakes, +3 authors 371 et al. DAPT Study Investigators. Twelve or 30 mont Med
  • Citation: Xu JJ, Gao Z, Song Y, Tang XF, Jiang L, et al.
  • 2017
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

Long-term use of ticagrelor in patients with prior myocardial infarction.

  • The New England journal of medicine
  • 2015
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

951-954

PA Gurbel, E Mahla, J 35TantryUSTheenigmaticsearchforoptimalDAPTduration
  • Citation: Xu JJ, Gao Z, Song Y, Tang XF, Jiang L, et al.
  • 2017
VIEW 1 EXCERPT